Summary
Background and objectives: Sarcopenia characterized by progressive and generalized loss of skeletal muscle mass and function with a risk of adverse outcomes such as. There is an important relationship between cirrhosis and muscle weakness (sarcopenia), as the liver plays a major role in the metabolism of all nutrients. The Aim of this study to assess muscle status and sarcopenia among patients with liver cirrhosis and its relation to patient physical activity and dietary history as well as liver disease progression. Method:
This was a cross-sectional study conducted on 150 cirrhotic patients attending to hepatology and gastroenterology department at Specialized Medical Hospital, Mansoura University. All patients underwent through clinical evaluation, laboratory investigation, and assessment of muscle status by anthropometric parameters and grip strength.
In addition, assessment of nutritional status and physical activity was done. Results: Of included participants, 80 patients (53.3%) were diagnosed with sarcopenia and pre-sarcopenia (39.3% sarcopenic and 14% pre-sarcopenia) and 70 patients with non sarcopenia or presarcopenia. Almost two-third of sarcopenic patients were men (66. 4%) versus (33.6%) were women. The sarcopenia and pre-sarcopenia patients were older than non-sarcopenia patients and had lower BMI with statistically significant difference. The majority of patients with sarcopenia consumed diet with low protein, low vitamin and iron contents with statistically significant difference versus non sarcopenic patients. On other hand, excess salt and minerals intake were common among sarcopenic and pre-sarcopenic patients. Assessment of physical activity among studied group by International Physical Activity Questionnaires (IPAQ) demonstrated that, 53% of sarcopenic and pre-sarcopenic patients exerted low or no exercise with statistically significant difference compared to non-sarcopenic group (only 12%). Frequency of complications of liver cirrhosis as ascites, hepatic encephalopathy and variceal bleeding were statistically significant higher in those patients with sarcopenia and pre-sarcopenia versus those without sarcopenia. There was significant hypoalbuminemia, hyperbilurbinemia and rising serum creatinine among sarcopenic patients versus nonsarcopenic patients. Positive statistically significant association detected between Sarcopenia and progression of liver diseases assessed by Child Pugh score and MELD score versus non sarcopenic patients. The independent predictive factors of sarcopenia analysed by logistic regression were increasing age, low BMI, low protein intake and hypoalbuminemia. Conclusion: The prevalence of sarcopenia is high in cirrhotic patients. It was highest in patients with older age, low BMI and low protein intake. Also, the worse the condition of the liver the greater the degree of muscle weakness was detected.
Keywords: Sarcopenia and pre-sarcopenia, liver cirrhosis, protein, vitamin variceal bleeding and hepatic encephalopathy hepatocellular carcinoma, severe muscle wasting or sarcopenia is considered one of frequent unseen complication which negatively impact survival and quality of life 2 . Sarcopenia is a disorder described by progressive loss of skeletal muscle mass and strength which associated with unfavorable outcomes such as poor quality of life, physical disability and even death 3 . Sarcopenia, as defined by muscle loss and dysfunction, is a common feature of all chronic inflammatory diseases and involve impairment of contractile, metabolic and endocrinal functions of the skeletal muscle 4 . Sarcopenia is one of the diagnostic hallmarks of malnutrition, a clinical condition that is often challenging to objectively define in patient with cirrhosis 5 . Balance between protein synthesis and protein breakdown plays important role in maintaining muscle mass. As cirrhotic patients have poor hepatic glycogen reserves due to the impaired synthetic capacity of hepatic cells, this leads to increase the utilization of amino acids as an energy source that accelerate the breakdown of skeletal muscle resulting in sarcopenia 6 . Sarcopenia is a crucial nutritional issue that is widely spread among patient with cirrhosis with prevalence 40% to 70%. Different screening procedures are used to identify sarcopenia earlier and to allow proper intervenetions 7 . Mild degree of muscle loss possibly occurs in all cirrhotic patients but the severity of sarcopenia measured by anthropometric assessment getting worse with increasing severity of liver disease measured by Child's score 8 . Diet one of the factors that may have direct effect on sarcopenia and functional status. Muscle mass weakening is related to different nutrient deficiencies including, protein, vitamin D, and antioxidant agents such as selenium and vitamins E and C especially in elderly 9 . On other hand, physical activity is an important determining factor of muscle anabolism 10 . Decreased physical activity can cause loss of skeletal muscle by a decrease in muscle protein synthesis. Conversely, loss of muscle mass and strength is associated with physical disability and it may cause patients to become disabled and stay inside 11 . The aim of our study was to assess muscle status and sarcopenia among patients with liver cirrhosis and it is relation to patient physical activity and dietary history as well as liver disease progression.
Patients and Methods
This cross-sectional study was carried out on 150 cirrhotic patients with liver cirrhosis atte-nding to hepatology and gastroenterology unit (outpatient clinic and inpatient ward). This study conducted from January 2017 to December 2017, at specialized medical hospital in Mansoura University. A) Inclusion criteria: Included, patients with liver cirrhosis, age 18 -60 year and patients able to communicate. B) Exclusion criteria: Patients with other system failure (e.g. renal failure, heart failure and respiratory failure). Patients with other systemic, endocrinal disease that can influence the muscle status e.g., myopathies, endocrinopathies like hypothyroidism and Cushing. Patients on chronic medications that can directly affect the muscle status e.g. steroids, colchicine and hydroxychloroquine. Patients with any condition that can limit their physical activity e.g chronic arthritis, systemic neuromuscular disease. Females during pregnancy, puerperium or lactation. Patients who are bed ridden due to any cause. All selected patient were subjected to; through history taking and complete physical examination including, stigmata of chronic liver disease, nutritional status and features of any nutritional deficiencies, assessment of Child-Pugh and MELD score. Abdominal ultrasound to assess liver, spleen size, and presence of ascites.
Laboratory investigation
Including, liver function tests (serum albumin, serum bilirubin, prothrombin time, ALT, AST), serum creatinine, Complete blood count, serum calcium, serum CPK. Anthropometric parameters and muscle status assessment * Measurement of weight, height and BMI. * Weight was sectioned into two measures: objective scale weight (kg) and subjective assessment of dry weight without ascites or pedal edema. Estimated dry weight (kg) was calculated using either the post paracentesis body weight or scale weight minus ascites weight based upon severity (mild: 5%; moderate: 10%; severe: 15 %). An additional 5% was subtracted if bilateral pedal edema was present. Body mass index (BMI) was measured using either scale or estimated dry weight divided by height (kg /m2) 12 . Assessment of muscle status a) Measurement of muscle power by grip strength Using Jamar Hand Dynamometer (JAMARTM handgrip dynamometer; Sammons Preston, Bolingbrook, IL). The American Society of Hand Therapists (ASHT) recommended standard position to be used: the patient was seated with shoulders adducted and neutrally rotated, elbow flexed at 90 degrees, and the forearm and the wrist in neutral position. The patients were verbally instructed to maintain their arm by their side with their shoulder in neutral position. Also, they were instructed neither extremely brace their arm against their trunk nor abduct their arm. The patients were also instructed to keep their wrists as neutral as possible although mild wrist extension is expected with power grip (0 -30 degrees of wrist extension is permissible by ASHT) 13 . Grip strength was measured from non-dominant hand. Three trials were conducted with approximately 30 s of resting time between the tests. The best attempt out of the three was recorded as the maximal result. Subjects were given verbal encouragement to maximize their effort.The scores of the hand was expressed in kilograms. Close attention was paid to make all three attempts in a similar 13 .The cut off value for diagnosis of sarcopenia was reported (Ohashi et al., 2018) as < 26 kg for men and <18 kg for women 14 . b) Measurement of muscle mass by using mid arm circumference and skin fold thickness. Mid arm circumference was measured at the midpoint between the tip of the acromion and the olecranon process on the non-dominant side of the body using a flexible tape measure. Triceps skin fold thickness was also taken on the non-dominant side of the body, with the patients standing in a relaxed position, using skin fold caliper. Mid-arm muscle circumference (MAMC) was calculated using the midarm circumference and triceps skin fold thickness according to a standard equation 15 : AMC (cm) = MAC (cm) -[3.14 x TSF (cm)]. The diagnosis of sarcopenia can be established when MAMC value is below the 10 th percentile from a reference population 16 . According to previous methods of assessment muscle status and criteria of sarcopenia, the studied group subdivided to: 1) Sarcopenic group (low muscle mass and strength). 2) Pre-sarcopenic group (low muscle mass or grip strength). 3) Non sarcopenia group (normal both muscle mass and strength). The patients diagnosed with pre sarcopenia or sarcopenia were considered as one group and compared to non sarcopenic group in this study. I. Questionnaire for assessment of physical activity. For assessment of physical activity we used The International Physical Activity Questionnaires (IPAQ) short version. The IPAQ short form asks about three specific types of activity include walking, moderateintensity activities and vigorous-intensity activities. The items in the short IPAQ form were structured to provide separate scores on walking, moderate-intensity and vigorous-intensity activity. Computation of the total score for the short form requires summation of the duration (in minutes) and frequency (days) of walking, moderate-intensity and vigorous-intensity activities 17 . According to IPAQ Scoring Protocol (Short Forms), patients had one of the three level of physical activity (low or moderate or vigorous) 18 . II. Questionnaire for Assessment of dietary history. Assessment different types and amount of nutrient taken by the patient per week by validated questionnaire and classify these amount either more than required, less than required or as required 19 . The study protocol was approved by medical ethics research team, Faculty of Medicine in Mansoura University.
Statistical analysis
Collected data were coded, computed and statistically analyzed using SPSS (statistical package of social sciences), version 16. Data were presented as frequency and percentages (quailtative variables) and mean ± SD (quantitative continuous variables). Chi square (2) was used for comparison of categorical variables. Student's t test was used for comparison of continuous quantitative variables (two groups) and it is replaced by Mann Whitney (Z) test if the data is not normally distributed. Multiple Logistic Regression Modeling was used as multivariate analysis to find the risk priority factors. The difference was considered significant at P ≤ 0.05.
Results
Table (1) shows that, sarcopenic and pre sarcopenic patients were elder than non sarcopenicpatients (86.2% at age above 50 year). Moreover, there is statistically significant difference regarding BMI between studied groups (p 0.001). All patients with low body weight (BMI<18) were sarcopenic. As regard obese patients (BMI≥30), 11 patients (13.8%) were sarcopenic versus 23 patients (32.9%) were non sarcopenic. On other hand, there is no significant difference as regard gender, smoking habits and different occupations between two groups. By applying multivariate analysis (Binary Logistic regression), it is found that percentage of predication of occurrence of sarcopenia or pre sarcopenia among patients with liver cirrhosis is 74.7%. The risk is significantly increased with age 50 years and above and patients with below average BMI. Table ( 2) shows dietary history and its relation to sarcopenia of the studied patients. Compared to non-sarcopenic patients, sarcopenic patients had low protein intake (p<0.0001), less carbohydrate and lipids than required (p<0.001). Furthermore, as regard minerals and salt, most of sarcopenic group received amount of mineral more than required (50%) (P<0.001). In contrary, majority of sarcopenic patient take amount of iron and vitamins less than required with significant difference (p<0.0001) versus non sarcopenic group . By applying multivariate analysis (Binary Logistic regression), it is found that percentage of predication of occurrence of sarcopenia and pre sarcopenia among patients with liver cirrhosis is 74.0%. The risk is significantly increased in patients taking less protein, less iron, more minerals and added salt. Table ( 3) demonstrates non-significant difference as regard DM, HTN and other associated diseases (cardiac or chest or neurological diseases) between two groups. However, there is significant difference as regard diabetic treatment (p 0.004) in which insulin is the therapy for most of diabetic patients of sarcopenic group (97%). Table (4) shows, significant difference as regard serum albumin, serum bilirubin, SGOT, serum creatinine between two groups. There is no significant difference as regard INR, SGPT, HB and platelets. Although there is no significant difference in serum calcium among studied group, 66% of sarcopenic had low serum calcium. Moreover, significance association presented between elevated WBCs and sarcopenic and pre sarcopenic group (30%). By applying multivariate analysis (Binary Logistic regression), it is found that percentage of predication of occurrence of sarcopenia or pre sarcopenia among patients with liver cirrhosis is 75.3%. The risk is significantly increased in patients with low albumin and those with high serum creatinine. Table (5) shows that, sarcopenia more prevalent with progression of liver disease as (72.5) of sarcopenic group had Child Pugh C classification while most of non sarcopenic group (55.7%) had child A classification with statistically significance (p<0.0001). Also, there is significant difference as regard MELD score between two groups as it was higher in sarcopenic group (12.64 ± 4.5) than the other (19.9± 6.9). Table (6) shows statistically significant differences as regard ascites, encephalopathy, jaundice and variceal bleeding between non sarcopenic and sarcopenia and pre sarcopenia patients (P<0.05). By applying multivariate analysis (Binary Logistic regretssion), it is found that percentage of predication of occurrence of sarcopenia & pre sarcopenia among patients with liver cirrhosis is 84.7%. The risk is significantly increased in patients with moderate and severe ascites and this reporting history of encephalopathy. Table (7) shows that, the creatine phosphokinase (CPK) was significantly increased in non sarcopenic group versus sarcopenic (p= 0.001). Figure  (1) shows, a significant association between sarcopenia and physical activity among studied patients (p<0.0001) as (52.5%) of sarcopenic group had low physical activity. Table ( 2) Dietary history and its relation to sarcopenia of the studied patients. Table ( 3) Associated diseases and relation to sarcopenia of the studied patients. 
Discussion
The prevalence of patients with muscle affection in our study was 53.3%, sarcopenia among participants was 39.3% (n=59) and presarcopenia was 14% (n=21). Close to this study, Giusto et al., found that the prevalence of sarcopenia was (51%) between studied patients 15 . However, higher result (70.3%) was reported in another study 20 . The prevalence of sarcopenia in the current study increased with age. It was 28.2% in age group <50 years and 62.2% in age group ≥50 years. Similar results were reported by another study that found the prevalence of sarcopenia increased with age in both men and women, as people aged 60 years and older having the highest prevalence rate 21 . Although there was no statistically significant difference as regard gender between sarcopenic and non sarcopenic group, the prevalence of sarcopenia tends to be more common in men than women (66.8% men versus 33.2% women of sarcopenic group). This sex difference may be related to the abundance of fat stores in females since females generate their energy more preferentially from fat stores than from skeletal muscle stores 22 . Women with sarcopenia may be at a more advanced stage of malnutrition because they have reached the point of requiring their muscle mass as an energy store. Also, the androgens deficiencies with hyperestrogenism in male patient with liver cirrhosis play a role in muscle status deterioration 23 . Also, we found that there was significant difference as regard BMI estimated by dry weight between sarcopenic and non sarcopenic patients (p<0.001) as all patients (100%) with low body weight (BMI<18.5) were sarcopenic. These results is in agreement with Hanai et al., who reported low body weight among sarcopenic patients. However, sarcopenia is not exclusive in under-weight patients but it constitutes a hidden condi-tion that can be present in cirrhotic patients with any BMI (55% of sarcopenia and pre-sarcopenia group had average body weight) 24 . For evaluation of nutritional status among studied patients, recent dietary intake was assessed using simple questionnaire. The protein intake was significantly lower in the sarcopenia group than in the non sarcopenic group as (61.2%) of sarcopenic patients take amount of protein less than required. This result is matched with study that detected low protein intake among patients with low skeletal muscle mass 21, 25 . Nearly one-quarter of sarcopenic patients utilized low amount of carbohydrate and lipid as required compared to non sarcopenic patients who consumed amount more than required. Adequate balance among the main macronutrient (protein, carbohydrate, and lipid) is important. As excess consumption of carbohydrate and lipid with reduced protein intake may increase incidence of sarcopenic obesity 26 . On other hand low carbohydrate and lipid intake among cirrhotic patient even with normal protein intake leads negative energy balance and thus promote the wasting of the skeletal muscle mass 27 . Natural minerals and added salts were given as more than required per clinical status in almost half of sarcopenic patients (50%) while as required in (40.3%). Only (8.8%) were receiving less than required. This reflects the poor compliance of the patients with recommendations as following negative orders like avoid protein, avoid salt, avoid iron. Regarding iron and vitamins supplem-entation in this study, most of sarcopenic group (46.2%) received amount less than required with statistically significant difference com-pared to non sarcopenic one. These results are in agreement with previous study demonstrated low intake of iron among sarcopenic group but no significant difference regarding vitamins intake between two groups 27 . Regarding other associated medical disease, the current study found that, the prevalence of DM in sarcopenic and pre-sarcopenia group and non sarcopenic groups was (45% and 40% respectively) with insignificant statistically difference. Although insulin considered one of the anabolic hormones, it was the line of treatment of DM for (97.2%) of sarcopenic and pre-sarcopenia patients. This apparent paradox result may be due to majority of cirrhotic patients postpone using insulin until late stage of liver disease when they become already sarcopenic. These results matched with Hara et al., who found that, the prevalence of DM among sarcopenic and normal groups were 40% and 24% respectively with insignificant statistically difference 28 . On the contrary, study done by Lee et al., revealed increase incidence of DM among sarcopenic group with significant difference to non sarcopenic one 29 . Regarding complications of liver cirrhosis including (ascites, HE, jaundice and variceal bleeding), the current study showed statistically significant difference bet-ween sarcopenic and non sarcopenic cases (p<0.001 35 who reported also statistically significant differences between two groups as regard to serum bilirubin level. As regard serum total calcium, the present study reported that there was a decrease of serum calcium level in sarcopenic cases related to non sarcopenic cases without statistically significant difference between both groups (P0.135). On other hand, significant higher levels of serum creatinine presented among sarcopenic and pre-sarcopenia group rather than non sarcopenic group. This is compatible with Nishikawa et al., who found increase serum creatinine and decrease estimated GFR among sarcopenic cases 35 . As regard Child Pugh score (CPS). The current study revealed that, prevalence of sarcopenia increased significantly with advancing liver disease according to the CPS. In addition, the MELD score was higher in sarcopenic and pre-sarcopenia group versus non-sarcopenic group (19.95±8.67 versus 12.64±6.9) with statistically significant differences (p value <0.001). These results are matched with some studies showing positive association between sarcopenia and both Child-Pugh or MELD scores 2 . On contrary, study done by Hanai et al., reported non significant difference between two studied group as regard child Pugh score and MELD score 24 . In this study, univariate and multivariate logistic regression analysis demonstrated that, incr-easing age, low dry BMI, less protein intake and high salt were a predictive risk factor for sarcopenia. Hypoalbuminemia had the highest odds ratio 55.1(9.8-566.5) and the most risk for increased incidence of sarcopenia. Furthe-rmore, the risk is significantly increased in patients with moderate and severe ascites and those reporting history of hepatic encephalopathy (OR 3.6 (1.5-8.6) and 5.6 (3.3-9.4) respectively).
Similar results were reported by Ohashi et al., as they found that independent predictive factors of sarcopenia were advanced age, low BMI and low PA 14 . The study faced multiple limitations as high financial cost of CT limits its use although it is considered the best method for diagnosis. Also, we depend on cutoff point not standardized for Egyptian populations. Finally, it was a cross-sectional study, thus we could not absolutely verify a causal relationship between PA or lifestyle and sarcopenia in patients with chronic liver disease. Future cohort studies are therefore needed.
Conclusion
Sarcopenia is one of the commonest complications of cirrhosis. The prevalence of sarcopenia was highest in patients with older age, low BMI and low protein intake. In addition, the worse the condition of the liver the greater the degree of muscle weakness was detected. Sarcopenia could be aggravated by the wrong dietary recommendations and habits. Awareness and education of the health team and patients regarding sarcopenia is of urgent need. Moreover, increase physical activity and practicing exercise can help in such situation. 
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